Clinical Research at MENA
37,75 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

The meaning of Clinical Trials for humans has recently changed significantly, "evolved", so to speak. In today's environment, where ethical validity is much more strictly controlled, this meaning is far beyond "human drug testing" and much closer to the "therapeutic goal". The number of clinical trials in western countries that have perceived this change has increased rapidly and continues to increase. Although the number of clinical studies in the MENA region is increasing day by day, it is still far from its potential. Among the reasons for this are legal, technological, ethical,…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The meaning of Clinical Trials for humans has recently changed significantly,
"evolved", so to speak. In today's environment, where ethical validity is much more
strictly controlled, this meaning is far beyond "human drug testing" and much closer
to the "therapeutic goal". The number of clinical trials in western countries that have
perceived this change has increased rapidly and continues to increase. Although
the number of clinical studies in the MENA region is increasing day by day, it is still
far from its potential. Among the reasons for this are legal, technological, ethical,
epidemiological, educational and economic factors. This book presents both the
difficulties encountered in conducting clinical trials in MENA and suggestions for
solving these difficulties.
Autorenporträt
Fatih Özdener graduated as a medical doctor from Hacettepe University Faculty of Medicine in 1990 and practiced clinical medicine in Turkey for 5 years. He obtained PhD in Pharmacology from Temple University in USA in 2000 and worked as a postdoctoral researcher at the same university prior to joining academia. Fatih Özdener has broad pharmaceutical industry experience at different local and regional medical functions including clinical operations, clinical quality and medical management in Turkey, Middle East and Africa. He has more than twenty publications in the fields of molecular and clinical pharmacology. Currently, he is a faculty member and a member of management board at Bahcesehir University School of Medicine and the program coordinator of Pharmaceutical Medicine master's degree program at the same university.